Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iveson

Showing results (451-460 of 573) with videos related to

Pageof 58
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trialsI Chau, A R Norman, D Cunningham, et al.
Molecular Imaging and Biology|February 29, 2012
In vivo pH imaging with (99m)Tc-pHLIPSven Macholl, Matthew S Morrison, Peter Iveson, et al.
The New England Journal of Medicine|January 4, 2008
Capecitabine and oxaliplatin for advanced esophagogastric cancerDavid Cunningham, Naureen Starling, Sheela Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumorsH J Andreyev, P Scott-Mackie, D Cunningham, et al.
Chronobiology International|December 17, 2013
Is there a diurnal variation in repeated sprint ability on a non-motorised treadmill?Samuel A Pullinger, Emma L Brocklehurst, Reece P Iveson, et al.
Clinical Epigenetics|April 23, 2026
The non-linear and linear effects of CYP2C19 metaboliser status on DNA methylation: a methylome-wide association studyChen Shen, Mark J Adams, Eleanor Davyson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2026
Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trialT S Varghese, S Faithfull, A Frampton, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancerNick Maisey, Ian Chau, David Cunningham, et al.
Pageof 58

Showing results (451-460 of 573) with videos related to

Sort By:
Pageof 58
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trialsI Chau, A R Norman, D Cunningham, et al.
Molecular Imaging and Biology|February 29, 2012
In vivo pH imaging with (99m)Tc-pHLIPSven Macholl, Matthew S Morrison, Peter Iveson, et al.
The New England Journal of Medicine|January 4, 2008
Capecitabine and oxaliplatin for advanced esophagogastric cancerDavid Cunningham, Naureen Starling, Sheela Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumorsH J Andreyev, P Scott-Mackie, D Cunningham, et al.
Chronobiology International|December 17, 2013
Is there a diurnal variation in repeated sprint ability on a non-motorised treadmill?Samuel A Pullinger, Emma L Brocklehurst, Reece P Iveson, et al.
Clinical Epigenetics|April 23, 2026
The non-linear and linear effects of CYP2C19 metaboliser status on DNA methylation: a methylome-wide association studyChen Shen, Mark J Adams, Eleanor Davyson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 19, 2026
Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trialT S Varghese, S Faithfull, A Frampton, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancerNick Maisey, Ian Chau, David Cunningham, et al.
Pageof 58